SENSEX 77181.62 (0.34) |
Nifty 50 23893.2 (0.35) |
Nifty Bank 55811.1 (0.49) |
Nifty IT 31885.85 (-2.05)|
Nifty Midcap 100 59300.2 (1.20) |
Nifty Next 50 70509.8 (1.27) |
Nifty Pharma 27312.35 (0.34) |
Nifty Smallcap 100 18969.65 (1.70) |
Today’s Low
2042.55
Today’s High
2180.80
Open
2053.30
Perv Close
1982.55
52W Low
906.20
52W High
1235.65
WeekChge
14.79
MonthChge
10.64
YearChge
62.25
P/E Ratio (TTM)
45.44
P/BV
195.60
EPS
43.63
FV
10
MCAP
37,611.08
Dividend Yield (%)
0.18
Volumes soar at Emcure Pharmaceuticals Ltd counter
Emcure Pharmaceuticals Ltd consolidated sales up 9.30% on year in Q3FY2026, net profit expanded by 11.14%
Emcure Pharmaceuticals Ltd consolidated sales up 9.30% on year in Q3FY2026, net profit improved by 11.14%
Emcure Pharmaceuticals to review quarterly results at board meeting November 3, 2026
Emcure Pharmaceuticals received a certificate from MUFG Intime India regarding securities dematerialization
Emcure Pharmaceuticals proposes merger with Zuventus and Emcutix, pending regulatory approvals
OI
OI Chg
Avg Price
Contracts Traded
Turnover(Cr)